Iovance Biotherapeutics, Inc.
IOVA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001425205
No open-market purchases or sales by Iovance Biotherapeutics, Inc. insiders were filed in the last 90 days; 293 institutions reported holding it in 13F filings for Q2 2026, worth $1.19B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Iovance Biotherapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 302
- +22 vs. Q3 2024
- Shares held
- 241.6M
- +7.89M (+3.4%) vs. Q3 2024
- Total value
- $1.79B
- −$407.3M (−18.6%) vs. Q3 2024
- New holders
- 58
- 101 more added
- Sold out
- 36
- 86 more reduced
6 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IOVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 293 | $1.19B |
| Q1 2026 | 286 | $943.8M |
| Q4 2025 | 263 | $713.7M |
| Q3 2025 | 253 | $462.3M |
| Q2 2025 | 255 | $379.3M |
| Q1 2025 | 303 | $798.9M |
| Q4 2024 | 302 | $1.79B |
| Q3 2024 | 286 | $2.21B |
| Q2 2024 | 295 | $1.86B |
| Q1 2024 | 273 | $3.22B |
| Q4 2023 | 236 | $1.69B |
| Q3 2023 | 228 | $970.0M |
| Q2 2023 | 219 | $1.44B |
| Q1 2023 | 230 | $1.25B |
| Q4 2022 | 218 | $1.11B |
| Q3 2022 | 242 | $1.48B |
| Q2 2022 | 238 | $1.75B |
| Q1 2022 | 248 | $2.60B |
| Q4 2021 | 246 | $2.96B |
| Q3 2021 | 244 | $3.88B |
| Q2 2021 | 234 | $4.22B |
| Q1 2021 | 252 | $4.98B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Iovance Biotherapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hemington Wealth Management | 13 | $0 | 0.00% | +4+44.4% | Added |
| Covestor Ltd | 16 | $0 | 0.00% | +1+6.7% | Added |
| Cutter Capital Management, LP | 0 | $0 | 0.00% | −876,009−100.0% | Sold out |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −750,000−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −500,033−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −218,927−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −217,928−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −184,400−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −135,000−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −109,953−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −92,368−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −61,009−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −57,188−100.0% | Sold out |
| Wealthspire Advisors, LLC | 0 | $0 | 0.00% | −53,705−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −35,200−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −25,824−100.0% | Sold out |
| Transcend Wealth Collective, LLC | 0 | $0 | 0.00% | −21,900−100.0% | Sold out |
| SeaCrest Wealth Management, LLC | 0 | $0 | 0.00% | −20,406−100.0% | Sold out |
| SkyView Investment Advisors, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| TCG Advisory Services, LLC | 0 | $0 | 0.00% | −18,686−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −17,484−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −15,800−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −15,342−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −15,071−100.0% | Sold out |
| Fairfield, Bush & Co. | 0 | $0 | 0.00% | −14,575−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −12,854−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −12,272−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −10,362−100.0% | Sold out |
| Inceptionr LLC | 0 | $0 | 0.00% | −10,040−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −9,900−100.0% | Sold out |
| Flputnam Investment Management Co | 0 | $0 | 0.00% | −240−100.0% | Sold out |
| Dunhill Financial, LLC | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Costello Asset Management, INC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Voisard Asset Management Group, Inc. | 0 | $0 | 0.00% | −273−100.0% | Sold out |
| Hobbs Group Advisors, LLC | 0 | $0 | 0.00% | −132−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −91−100.0% | Sold out |
| CVA Family Office, LLC | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Eagle Asset Management Inc | – | – | – | – | Not filed |
| Raymond James Financial Services Advisors, Inc. | – | – | – | – | Not filed |
| Raymond James & Associates | – | – | – | – | Not filed |
| Abich Financial Wealth Management LLC | – | – | – | – | Not filed |
| ClariVest Asset Management LLC | – | – | – | – | Not filed |
| Planning Capital Management Corp | – | – | – | – | Not filed |